{"product_id":"acg-postgraduate-course-2021","title":"ACG Postgraduate Course 2021","description":"\u003cdiv class=\"prod-title\"\u003e\n\u003cdiv class=\"form-group\"\u003e\n\u003cdiv class=\"form-control-plaintext\"\u003e\n\u003cdiv class=\"form-group\"\u003e\n\u003cdiv id=\"block-pagetitle\"\u003e\n\u003ch1 class=\"product-title product_title entry-title\"\u003eACG Postgraduate Course 2021+\u003c\/h1\u003e\n\u003cp\u003e\u003cb\u003eSaturday, October 23, 2021\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eSession 1A: Easing the Esophageal Enigma\u003c\/strong\u003e\u003cbr\u003e\n\u003cem\u003eModerator: Nicholas J. Shaheen, MD, MPH, MACG\u003c\/em\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eEsophageal Motility Disorders: Taming the Tube?\u003c\/strong\u003e\u003cbr\u003e\n\u003cem\u003eRena H. Yadlapati, MD, MSHS\u003c\/em\u003e\u003cbr\u003e\nProvide an overview of esophageal motility disorders, with recommendations for updated management in 2021.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eEoE – To Dilate or To Medicate?\u003c\/strong\u003e\u003cbr\u003e\n\u003cem\u003eEvan S. Dellon, MD, MPH, FACG\u003c\/em\u003e\u003cbr\u003e\nDescribe current management strategies for EoE, from dietary management to medications, with an algorithm for practice.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eBarrett’s Esophagus – Burn, Freeze, or Observe? Dysplasia Update\u003c\/strong\u003e\u003cbr\u003e\n\u003cem\u003eNicholas J. Shaheen, MD, MPH, MACG\u003c\/em\u003e\u003cbr\u003e\nProvide an overview of screening, surveillance, and treatment of Barrett’s in 2021.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eManagement of Reflux: Effective Use of PPIs and Beyond\u003c\/strong\u003e\u003cbr\u003e\n\u003cem\u003eMichael F. Vaezi, MD, PhD, MSc (Epi), FACG\u003c\/em\u003e\u003cbr\u003e\nDescribe a practical approach to the diagnosis and management of reflux, plus the role of and risks\/benefits of PPIs, as well as treatment duration recommendations, and management of PPI-refractory patients.\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003ePanel Q \u0026amp; A\u003c\/strong\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eThe David Sun Lecture – Colon Polyps: Going and Gone\u003c\/strong\u003e\u003cbr\u003e\n\u003cem\u003eJerome D. Waye, MD, MACG\u003cbr\u003e\nIntroduced by: David A. Greenwald, MD, FACG, ACG President\u003c\/em\u003e\u003cbr\u003e\nExplain the history of colon polyps and what may happen in the future.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eSession 1B: Colonoscopy Pearls – Optimizing the Yield\u003c\/strong\u003e\u003cbr\u003e\n\u003cem\u003eModerator: Douglas K. Rex, MD, MACG\u003c\/em\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eColorectal Cancer Screening and Surveillance – A Case-Based Approach and Guideline Review in 2021\u003c\/strong\u003e\u003cbr\u003e\n\u003cem\u003eAasma Shaukat, MD, MPH, FACG\u003c\/em\u003e\u003cbr\u003e\nProvide an evidence-based approach for the practicing clinician on colon cancer screening and surveillance of polyps in 2021, including an update on the most recent ACG guidelines.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eOptimal Polypectomy Techniques\u003c\/strong\u003e\u003cbr\u003e\n\u003cem\u003eDouglas K. Rex, MD, MACG\u003c\/em\u003e\u003cbr\u003e\nIdentify best practices for visualization of polyps and for polypectomy to maximize completeness of resection.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eDisparities in Colon Cancer Screening: How Do We Move the Needle?\u003c\/strong\u003e\u003cbr\u003e\n\u003cem\u003eDarrell M. Gray, II, MD, MPH, FACG\u003c\/em\u003e\u003cbr\u003e\nAssess ethnic\/gender disparities in colon cancer screening and colon cancer outcomes, and implement a practical strategy for improved access to screening in practice.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eEndoscopic and Non-Endoscopic Technologies for Colon Cancer Screening – What Lies Ahead of Us?\u003c\/strong\u003e\u003cbr\u003e\n\u003cem\u003eMark B. Pochapin, MD, FACG\u003c\/em\u003e\u003cbr\u003e\nReview the recent and future technologies, both endoscopic and non-endoscopic, for colon cancer screening that will assist gastroenterologists now and in the future.\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003ePanel Q \u0026amp; A\u003c\/strong\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eSession 1C: Pancreatic Disease 101\u003c\/strong\u003e\u003cbr\u003e\n\u003cem\u003eModerator: Timothy B. Gardner, MD, MS, FACG\u003c\/em\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eAcute Pancreatitis – Common and Unusual Causes, and Optimal Management in 2021\u003c\/strong\u003e\u003cbr\u003e\n\u003cem\u003eTimothy B. Gardner, MD, MS, FACG\u003c\/em\u003e\u003cbr\u003e\nReview common and uncommon causes of acute pancreatitis, and optimal management based on current guidelines.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePancreatic Cystic Lesions – When to Worry: Cases to Consider\u003c\/strong\u003e\u003cbr\u003e\n\u003cem\u003eLinda S. Lee, MD, FACG\u003c\/em\u003e\u003cbr\u003e\nExplain the different types of pancreatic cysts, their endoscopic, radiographic, and cytologic characteristics, and optimal management strategies.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eChronic Pancreatitis – Pearls in Pain Management\u003c\/strong\u003e\u003cbr\u003e\n\u003cem\u003eDarwin L. Conwell, MD, MS, FACG\u003c\/em\u003e\u003cbr\u003e\nReview the causes and natural history of chronic pancreatitis as well as best management strategies for treating chronic pain.\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003ePanel Q \u0026amp; A\u003c\/strong\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eSimultaneous Symposia\u003cbr\u003e\n\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp class=\"m-b-0\"\u003e\u003cstrong\u003eSymposium A: Women’s Health in IBD\u003c\/strong\u003e\u003cbr\u003e\n\u003cem\u003eModerator: Sunanda V. Kane, MD, MSPH, FACG\u003c\/em\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eContraceptive and Pre-Conception Counseling in IBD by the Gastroenterologist\u003c\/strong\u003e\u003cbr\u003e\n\u003cem\u003eMarla C. Dubinsky, MD\u003c\/em\u003e\u003cbr\u003e\nReview contraceptive strategies for women with IBD, and appropriate pre-conception counseling from the gastroenterologist.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eManagement of IBD During Pregnancy: Implications for Mother and Baby\u003c\/strong\u003e\u003cbr\u003e\n\u003cem\u003eSunanda V. Kane, MD, MSPH, FACG\u003c\/em\u003e\u003cbr\u003e\nAnalyze strategies for management of IBD prior to, during, and post-pregnancy, including infant outcomes associated with advanced therapies.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMenopause and Beyond: The Older Adult With IBD\u003c\/strong\u003e\u003cbr\u003e\n\u003cem\u003eBharati Kochar, MD, MSCR\u003c\/em\u003e\u003cbr\u003e\nDescribe the physiologic changes with aging, the role of menopause in IBD, and considerations for management of the older adult with IBD.\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003ePanel Q \u0026amp; A\u003c\/strong\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp class=\"m-b-0\"\u003e\u003cstrong\u003eSymposium B: A Focus on \u003cem\u003eClostridioides difficile\u003c\/em\u003e\u003c\/strong\u003e\u003cbr\u003e\n\u003cem\u003eModerator: Colleen R. Kelly, MD, FACG\u003c\/em\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eManagement of \u003cem\u003eC. diff\u003c\/em\u003e: Update on ACG Guidelines\u003c\/strong\u003e\u003cbr\u003e\n\u003cem\u003eColleen R. Kelly, MD, FACG\u003c\/em\u003e\u003cbr\u003e\nProvide an overview of the ACG guidelines for the management of \u003cem\u003eC. difficile\u003c\/em\u003e enterocolitis.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003e\u003cem\u003eC. diff\u003c\/em\u003e in IBD: When to Escalate or De-Escalate IBD Therapy\u003c\/strong\u003e\u003cbr\u003e\n\u003cem\u003eJessica R. Allegretti, MD, MPH, FACG\u003c\/em\u003e\u003cbr\u003e\nOutline strategies for management of \u003cem\u003eC. difficile\u003c\/em\u003e in IBD patients, including management of their IBD therapies.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eEvolving Probiotic, Antibiotic, and Designer Transplant Therapies – Optimizing the Microbiome\u003c\/strong\u003e\u003cbr\u003e\n\u003cem\u003ePaul Feuerstadt, MD, FACG\u003c\/em\u003e\u003cbr\u003e\nDescribe utilization of fecal transplant in practice, including an algorithmic approach and a guide to discussing the risks and benefits and modalities available (including considerations during the COVID era) to describe novel microbiome-based therapeutics for \u003cem\u003eC. difficile\u003c\/em\u003e.\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003ePanel Q \u0026amp; A\u003c\/strong\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp class=\"m-b-0\"\u003e\u003cstrong\u003eSymposium C: The Latest Frontiers of Endoscopy\u003c\/strong\u003e\u003cbr\u003e\n\u003cem\u003eModerator: Christopher C. Thompson, MD, MSc, FACG\u003c\/em\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eERCP – Tips for Difficult Cannulations\/Special Populations\u003c\/strong\u003e\u003cbr\u003e\n\u003cem\u003eShivangi T. Kothari, MD, FACG\u003c\/em\u003e\u003cbr\u003e\nReview the best practices for cannulation of the ampulla and approaches for special populations such as gastric bypass patients and pregnant patients.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePOEM\/ESD – Efficacy and Practicality: Cases to Behold\u003c\/strong\u003e\u003cbr\u003e\n\u003cem\u003eChristopher C. Thompson, MD, MSc, FACG\u003c\/em\u003e\u003cbr\u003e\nReview the role of POEM and ESD in the treatment of various GI luminal tract pathologies.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eEndoscopic Management of Obesity\u003c\/strong\u003e\u003cbr\u003e\n\u003cem\u003eAllison R. Schulman, MD, MPH\u003c\/em\u003e\u003cbr\u003e\nReview the current state and evidence-based data of endoscopic obesity management.\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003ePanel Q \u0026amp; A\u003c\/strong\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cb\u003eSunday, October 24, 2021\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eSession 2A: Hepatology 101\u003c\/strong\u003e\u003cbr\u003e\n\u003cem\u003eModerator: Amit Singal, MD, MS\u003c\/em\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eHCC 101 – Screening, Surveillance, Treatment\u003c\/strong\u003e\u003cbr\u003e\n\u003cem\u003eAmit Singal, MD, MS\u003c\/em\u003e\u003cbr\u003e\nIdentify best practices for diagnosis, management, and treatment for hepatocellular carcinoma, which continues to increase in incidence.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eNAFLD\/NASH – Optimizing Therapies for Maximal Benefit\u003c\/strong\u003e\u003cbr\u003e\n\u003cem\u003eKaren L. Krok, MD\u003c\/em\u003e\u003cbr\u003e\nReview the most effective management strategies to help mitigate NASH and prevent long-term sequelae, as well as review non-invasive diagnostic techniques for fibrosis.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eDILI – What Did You Take? A Case-Based Approach\u003c\/strong\u003e\u003cbr\u003e\n\u003cem\u003eNaga P. Chalasani, MD, FACG\u003c\/em\u003e\u003cbr\u003e\nReview the most common causative agents of drug-induced liver injury, including CAM therapies and herbal supplements.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eCirrhosis 101: Important Pearls for the Management of the Inpatient and Outpatient Cirrhotic – A Case-Based Approach\u003c\/strong\u003e\u003cbr\u003e\n\u003cem\u003eJoseph Ahn, MD, MS, MBA, FACG\u003c\/em\u003e\u003cbr\u003e\nApply optimal management strategies including algorithms to prevent and minimize long-term complications of cirrhosis such as HRS, variceal bleeding, SBP, and hepatoencephalopathy.\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003ePanel Q \u0026amp; A\u003c\/strong\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eSession 2B: Practical Pearls for the Management of Inflammatory Bowel Disease – A Case-Based Approach\u003c\/strong\u003e\u003cbr\u003e\n\u003cem\u003eModerator: Millie D. Long, MD, MPH, FACG\u003c\/em\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eThe Naïve Crohn’s Disease Patient – A Case-Based Approach\u003c\/strong\u003e\u003cbr\u003e\n\u003cem\u003eJill K. J. Gaidos, MD, FACG\u003c\/em\u003e\u003cbr\u003e\nOptimize initial therapies and management for the naïve Crohn’s disease patient, and identify which initial therapies are best for different CD phenotypes.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eUlcerative Colitis: Right Patient, Right Therapy\u003c\/strong\u003e\u003cbr\u003e\n\u003cem\u003eCorey A. Siegel, MD, MS\u003c\/em\u003e\u003cbr\u003e\nDescribe risk stratification of patients with UC and positioning of therapies in moderate to severe UC.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePreventing IBD-Related Complications: Practical Advice\u003c\/strong\u003e\u003cbr\u003e\n\u003cem\u003eMillie D. Long, MD, MPH, FACG\u003c\/em\u003e\u003cbr\u003e\nDescribe risks associated with medical therapies for IBD and practical recommendations for prevention.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePost-Operative Management of Crohn’s Disease: An Algorithm for Practice\u003c\/strong\u003e\u003cbr\u003e\n\u003cem\u003eMiguel D. Regueiro, MD, FACG\u003c\/em\u003e\u003cbr\u003e\nApply evidence-based treatment approaches to the post-operative management of Crohn’s disease.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eTherapeutic Drug Monitoring in IBD: Where Do We Stand?\u003c\/strong\u003e\u003cbr\u003e\n\u003cem\u003eDavid T. Rubin, MD, FACG\u003c\/em\u003e\u003cbr\u003e\nDescribe a practical and evidence-based approach to TDM utilization in practice.\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003ePanel Q \u0026amp; A\u003c\/strong\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eSession 2C: Functional Disorders in Practice\u003c\/strong\u003e\u003cbr\u003e\n\u003cem\u003eModerator: William D. Chey, MD, FACG\u003c\/em\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eFunctional Abdominal Pain: A Primer for the Gastroenterologist\u003c\/strong\u003e\u003cbr\u003e\n\u003cem\u003eBrian E. Lacy, MD, PhD, FACG\u003c\/em\u003e\u003cbr\u003e\nDescribe the use of neuromodulators in clinical practice for the management of functional abdominal pain and irritable bowel syndrome.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eDietary Management of IBS: A Recipe for Success\u003c\/strong\u003e\u003cbr\u003e\n\u003cem\u003eWilliam D. Chey, MD, FACG\u003c\/em\u003e\u003cbr\u003e\nIncorporate recommendations for dietary management of irritable bowel syndrome into the 15-minute office visit.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAn Evidence-Based Algorithmic Approach for IBS-C and D\u003c\/strong\u003e\u003cbr\u003e\n\u003cem\u003eLin Chang, MD, FACG\u003c\/em\u003e\u003cbr\u003e\nProvide an update on optimal management of IBS subtypes in 2021 and an algorithm for stepwise management in practice.\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003ePanel Q \u0026amp; A\u003c\/strong\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eSimultaneous Symposia\u003cbr\u003e\n\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp class=\"m-b-0\"\u003e\u003cstrong\u003eSymposium D: Endoscopic Emergencies – A Case-Based Approach\u003c\/strong\u003e\u003cbr\u003e\n\u003cem\u003eModerator: David A. Greenwald, MD, FACG\u003c\/em\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eForeign Bodies – The 3AM Call\u003c\/strong\u003e\u003cbr\u003e\n\u003cem\u003eDavid A. Greenwald, MD, FACG\u003c\/em\u003e\u003cbr\u003e\nOutline tricks, techniques, and the latest technologies to help remove common and unusual ingested foreign objects.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eUpper GI Bleeding – Non-Variceal Bleeding\u003c\/strong\u003e\u003cbr\u003e\n\u003cem\u003eAlan N. Barkun, MD, CM, MSc (Clin Epi), FACG\u003c\/em\u003e\u003cbr\u003e\nReview novel and best practices for the treatment of upper GI tract sources of bleeding.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eLower GI Bleeding – When Do You Scope versus Sleep?\u003c\/strong\u003e\u003cbr\u003e\n\u003cem\u003eLisa L. Strate, MD, MPH, FACG\u003c\/em\u003e\u003cbr\u003e\nDescribe the most recent evidence-based guidelines reviewing the role of urgent colonoscopic evaluation versus careful observation versus radiographic therapeutic approaches for lower gastrointestinal bleeding.\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003ePanel Q \u0026amp; A\u003c\/strong\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp class=\"m-b-0\"\u003e\u003cstrong\u003eSymposium E: Anorectal Pathology – A Case-Based Approach\u003c\/strong\u003e\u003cbr\u003e\n\u003cem\u003eModerator: Satish S. C. Rao, MD, PhD, FACG\u003c\/em\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eRecognizing and Treating HPV, AIN, and Anal Carcinoma\u003c\/strong\u003e\u003cbr\u003e\n\u003cem\u003eJessica D. Korman, MD\u003c\/em\u003e\u003cbr\u003e\nDiscuss the natural history of anal intraepithelial neoplasia, as well as which populations to screen and best practices for evaluation and treatment.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eDiagnosing the Causes of Defecation Difficulties – Clinical Pearls\u003c\/strong\u003e\u003cbr\u003e\n\u003cem\u003eSatish S. C. Rao, MD, PhD, FACG\u003c\/em\u003e\u003cbr\u003e\nReview pelvic floor dyssynergia, and the diagnosis and treatment options for defecatory disorders.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eFissures, Fistulas, Hemorrhoids, Oh My!\u003c\/strong\u003e\u003cbr\u003e\n\u003cem\u003eDarren M. Brenner, MD, FACG\u003c\/em\u003e\u003cbr\u003e\nExplain the unusual but important pelvic pathologies that tend to cause significant patient discomfort but are often overlooked.\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003ePanel Q \u0026amp; A\u003c\/strong\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp class=\"m-b-0\"\u003e\u003cstrong\u003eSymposium F: Conquering the Abyss: Small Bowel Pathologies, Enteropathies, and Other Rare Zebras That Should Be on Everyone’s List\u003c\/strong\u003e\u003cbr\u003e\n\u003cem\u003eModerator: David J. Hass, MD, FACG\u003c\/em\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eObscure Pathologies of the Small Bowel – A Case-Based Approach\u003c\/strong\u003e\u003cbr\u003e\n\u003cem\u003eDavid J. Hass, MD, FACG\u003c\/em\u003e\u003cbr\u003e\nReview common and uncommon pathologies of the small bowel, including bleeding, IBD, and small bowel neoplastic disease.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eManaging Celiac and Other Enteropathies – A Case-Based Approach\u003c\/strong\u003e\u003cbr\u003e\n\u003cem\u003eAmy S. Oxentenko, MD, FACG\u003c\/em\u003e\u003cbr\u003e\nReview the diagnosis and management of celiac, refractory celiac, and other often overlooked enteropathies.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eZebras Worth Knowing – A Review of Unusual Diagnoses That Should Be in Every Gastroenterologist’s Differential\u003c\/strong\u003e\u003cbr\u003e\n\u003cem\u003eLawrence J. Brandt, MD, MACG\u003c\/em\u003e\u003cbr\u003e\nReview unusual diagnoses that are not often considered but are high-yield and should be included in every gastroenterologist’s differential diagnosis.\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003ePanel Q \u0026amp; A\u003c\/strong\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n","brand":"My Store","offers":[{"title":"Default Title","offer_id":42954643603554,"sku":"MED-AMB07404","price":65.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0662\/9549\/6802\/files\/ACG-Postgraduate-Course-2021-scaled-768x768-1.jpg?v=1779381498","url":"https:\/\/meducourse.com\/products\/acg-postgraduate-course-2021","provider":"Meducourse","version":"1.0","type":"link"}